1. Home
  2. BLFS vs CSWC Comparison

BLFS vs CSWC Comparison

Compare BLFS & CSWC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLFS
  • CSWC
  • Stock Information
  • Founded
  • BLFS 1987
  • CSWC 1961
  • Country
  • BLFS United States
  • CSWC United States
  • Employees
  • BLFS N/A
  • CSWC N/A
  • Industry
  • BLFS Medical/Dental Instruments
  • CSWC Textiles
  • Sector
  • BLFS Health Care
  • CSWC Consumer Discretionary
  • Exchange
  • BLFS Nasdaq
  • CSWC Nasdaq
  • Market Cap
  • BLFS 1.1B
  • CSWC 1.0B
  • IPO Year
  • BLFS 1989
  • CSWC N/A
  • Fundamental
  • Price
  • BLFS $21.38
  • CSWC $20.80
  • Analyst Decision
  • BLFS Strong Buy
  • CSWC Hold
  • Analyst Count
  • BLFS 7
  • CSWC 3
  • Target Price
  • BLFS $30.57
  • CSWC $22.67
  • AVG Volume (30 Days)
  • BLFS 602.5K
  • CSWC 472.6K
  • Earning Date
  • BLFS 05-08-2025
  • CSWC 05-14-2025
  • Dividend Yield
  • BLFS N/A
  • CSWC 12.31%
  • EPS Growth
  • BLFS N/A
  • CSWC N/A
  • EPS
  • BLFS N/A
  • CSWC 1.47
  • Revenue
  • BLFS $87,762,000.00
  • CSWC $204,439,000.00
  • Revenue This Year
  • BLFS $21.21
  • CSWC $12.93
  • Revenue Next Year
  • BLFS $17.58
  • CSWC $14.56
  • P/E Ratio
  • BLFS N/A
  • CSWC $14.17
  • Revenue Growth
  • BLFS 34.80
  • CSWC 14.77
  • 52 Week Low
  • BLFS $18.70
  • CSWC $17.46
  • 52 Week High
  • BLFS $29.55
  • CSWC $27.23
  • Technical
  • Relative Strength Index (RSI)
  • BLFS 43.02
  • CSWC 51.80
  • Support Level
  • BLFS $21.48
  • CSWC $20.57
  • Resistance Level
  • BLFS $22.72
  • CSWC $20.84
  • Average True Range (ATR)
  • BLFS 1.02
  • CSWC 0.41
  • MACD
  • BLFS -0.12
  • CSWC -0.01
  • Stochastic Oscillator
  • BLFS 31.11
  • CSWC 33.33

About BLFS BioLife Solutions Inc.

BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.

About CSWC Capital Southwest Corporation

Capital Southwest Corp is a U.S.-based investment company that specializes in providing customized financing to middle market companies across various industries. The company's investment objective is to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnerships with business owners, management teams, and financial sponsors. The company's portfolio may include senior debt, second lien, and subordinated debt, preferred stocks, common stocks, and warrants. The primary source company's revenue comprises interest income and dividend income from investments made as well as management fees.

Share on Social Networks: